Clinical Study on the Safety and Efficacy of CD19-BCMA CAR-T Cell Therapy for Connective Tissue Diseases

NCT07152223 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Connective Tissue Diseases

Interventions

BIOLOGICAL: CAR-T

Sponsor

Guangzhou Bio-gene Technology Co., Ltd